News

- 6TH FEBRUARY 2026
Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the January 2026 concessionary price for Rosuvastatin 10mg tablets and Trimethoprim 100mg tablets: Drug Pack size Price concession Rosuvastatin 10mg tablets 28 £4.84 (previously £2.70) Trimethoprim 100mg tablets 28 £4.08 (previously £3.77) The
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 5TH FEBRUARY 2026
MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management and cardiovascular risk reduction. Patients reporting a sudden loss of vision (including partial loss) while
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 5TH FEBRUARY 2026
Rolled over price concessions for February 2026
The following price concessions granted in January 2026 have rolled over to February 2026: Drug Pack size January 2026 price concession Captopril 12.5mg tablets 56 £27.95 Captopril 25mg tablets 56 £25.95 Captopril 50mg tablets 56 £26.95 Codeine 15mg/5ml linctus sugar free 200 £17.34 Fusidic acid 1% modified-release eye drops 5 £35.00 Pyridoxine 10mg tablets 28
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 4TH FEBRUARY 2026
MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)
MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) Drug Alert Number: EL(26)A/07 Date issued: 04 February 2026 Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. DMRC reference
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 4TH FEBRUARY 2026
January 2026 Price Concessions Final Update
The Department of Health and Social Care (DHSC) has today (04/02/2026) confirmed the following final list of price concessions for January 2026. Drug Pack size Price concession Ascorbic acid 200mg tablets 28 £47.05 Captopril 12.5mg tablets 56 £27.95 Captopril 25mg tablets 56 £25.95 Captopril 50mg tablets 56 £26.95 Carvedilol 6.25mg tablets 28 £1.20 Chlordiazepoxide 10mg capsules
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News

- 4TH FEBRUARY 2026
Lords warn medicine shortages now a national security risk
A new report from the House of Lords Public Services Committee calls for better data sharing and a more proactive Government approach to managing medicines shortages, describing medicines supply as “a national security issue”. Published today (4th February), the report on the Lords Committee’s inquiry into medicines security concludes that the UK is heavily dependent
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 3RD FEBRUARY 2026
Category H: guidance and support for pharmacy owners
Community Pharmacy England is releasing guidance ahead of a webinar to explain Category H, the new Drug Tariff category, to pharmacy owners. We have published a comprehensive guide to the new Category H, explaining how entry to and price-setting arrangements for Category H will operate, as well as the background to these changes. Briefing: Category H FAQs Category H webpage List of products moving
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 3RD FEBRUARY 2026
MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed)
MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed) Drug alert number: EL(26)A/06 Date issued: 3 February 2026 Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution. DMRC reference number: DMRC-38317957 Company name:Syri Limited, T/A SyriMed Medicine Details
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 2ND FEBRUARY 2026
MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd)
MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) Drug alert number: EL(26)A/05 Date issued: 2 February 2026 Accord Healthcare limited is recalling a single batch due to an out of specification test result. DMRC reference number: DMRC-38091819 Company name: Accord Healthcare Ltd Medicine Details Carmustine
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 1ST FEBRUARY 2026
11 products added to the Discount Not Deducted (DND) list from February 2026
Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 11 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 February 2026. This takes the total
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News

Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026

MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Rolled over price concessions for February 2026

MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)

January 2026 Price Concessions Final Update

Lords warn medicine shortages now a national security risk

Category H: guidance and support for pharmacy owners

MHRA Class 2 Medicines Recall: Baclofen 10mg/5ml Oral Solution (Syri Limited, T/A SyriMed)

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd)

11 products added to the Discount Not Deducted (DND) list from February 2026

OUR OFFICE

CONTACT US

MESSAGE US

Contact Us

Quick Links

Our LPCs